Trader: Time To Get...
Health Care: Health Services
Genomic Health Inc. (GHDX: NASDAQ)
$33.60 0.40 | 1.20%
05/24/12 - 10:48 AM ET
63.63K / 163.80K
Vol / Avg. Vol:33.50 / 33.20
Open / Prev. Close:33.34 - 33.85
Today's Range:19.00 - 35.00
52 Wk Range:30.76%
Performance YTD:TheStreet Rating:
Portfolios with GHDX
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- UserGFNN Stockdiagnostics 16
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks With Big Insider Buy...
- UserGFNN Stockdiagnostics 5
- ContributorStocks With Big Insider Buy...
- ContributorStocks Rising On Unusual Vo...
- ContributorTop-Rated Biotechnology Stocks
- ContributorStocks At New 52-Week Highs...
- ContributorStocks With Big Insider Buy...
Latest GHDX Headlines from TheStreet
- 8 Stocks Rising on Big Volume 05.21.12 | 01:05 pm
- Insiders Trading VRX, RAX, GHDX 05.17.12 | 08:05 am
- Genomic Health Reaches New 52-Week High (GHDX) 05.14.12 | 11:05 am
- Insiders Trading GHDX, PDH, RPRX 05.14.12 | 09:05 am
- 5 Stocks Feeling the Insider Love 05.10.12 | 12:05 pm
- Insiders Trading GMCR, GHDX, TAL, SUPN 05.09.12 | 09:05 am
- Genomic Health Inc. Stock Downgraded (GHDX) 04.13.12 | 06:04 am
- Genomic Health Reaches New 52-Week High (GHDX) 03.05.12 | 03:03 pm
- Insiders Trading GHDX, CIE, DNI 03.01.12 | 09:03 am
- Insiders Trading GHDX, THLD, RVBD 02.24.12 | 09:02 am
Press Releases for GHDX
- Genomic Health Announces Presentation Of Eighteen Studies Highlighting Progress In Breast, Colon And Prostate Cancers At The American Society Of Clinical Oncology 2012 Annual Meeting - PR Newswire 05.16.12 | 06:05 pm
- Genomic Health Announces Presentation Of Three Oncotype DX® Studies At The 8th European Breast Cancer Conference - PR Newswire 03.21.12 | 03:03 am
- Genomic Health Announces Presentation Of Three Oncotype DX® Studies At The 8th European Breast Cancer Conference - PR Newswire 03.21.12 | 03:03 am
- Genomic Health Announces Formation Of New Genetics Subsidiary - PR Newswire 02.06.12 | 04:02 pm
- Genomic Health Presents Results Furthering Understanding Of Biology Of Prostate Cancer At The 2012 Genitourinary Cancers Symposium - PR Newswire 02.03.12 | 08:02 am
- Genomic Health To Announce Fourth Quarter And Year-End 2011 Financial Results And Host Conference Call On Monday, February 6, 2012 - PR Newswire 01.30.12 | 04:01 pm
- Genomic Health Announces Initiation Of Clinical Validation Study Of Prostate Cancer Test; Acceleration Of Next Generation Sequencing Program - PR Newswire 01.09.12 | 08:01 am
- Genomic Health To Present At The J.P. Morgan Healthcare Conference - PR Newswire 01.03.12 | 08:01 am
- Genomic Health Announces Results From Fourteen Studies Emphasizing Belief Of Physicians Around The World In The Value Of Oncotype DX - PR Newswire 12.12.11 | 08:12 am
- Genomic Health Announces Positive Results Of First Clinical Outcomes Study For Biomarker Discovery Using Next Generation Sequencing At The 2011 CTRC-AACR San Antonio Breast Cancer Symposium - PR Newswire 12.08.11 | 08:12 am
Partner Headlines for GHDX
- 4 Stocks With Heavy Insider Buying - Seeking Alpha 02.24.12 | 08:02 am
- Myriad Beats, Raises Guidance - Analyst Blog - Zacks 02.01.12 | 09:02 am
- 17 Breakout Stocks Boosted By Insiders - Seeking Alpha 12.30.11 | 04:12 pm
- Top 14 Rebound Stocks Backed Up By Insider Buying - Seeking Alpha 12.30.11 | 05:12 am
- 4 Healthcare Stocks With Smart Money And Insider Buying - Seeking Alpha 09.09.11 | 06:09 pm
- Taking On Healthcare Costs via the Private Sector - Seeking Alpha 06.20.11 | 07:06 am
- Genomic Makes New Advances - Analyst Blog - Zacks 05.25.11 | 06:05 pm
- Genomic's Success on Oncotype DX - Analyst Blog - Zacks 03.18.11 | 06:03 pm
- Top 15 Healthcare Stocks With Bearish Options Sentiment - Seeking Alpha 01.10.11 | 08:01 am
- Positive Data from Genomic Health - Analyst Blog - Zacks 12.10.10 | 05:12 pm
